CompletedNot Applicable

the Pericapsular Nerve Group (PENG) and Suprainguinal Fascia Iliaca Blocks (SIFIB) in Elderly Patients

Turkey (Türkiye)75 participantsStarted 2022-01-01

Plain-language summary

This clinical trial aims to compare the effect of the pericapsular nerve group (PENG) and suprainguinal fascia iliaca blocks (SIFIB) on pain management in elderly patients with subtrochanteric femur fractures. The participants will be patients determined to have proximal femoral nailing. According to randomisation, each participant will receive either PENG or SIFIB postoperatively after spinal anaesthesia. The investigator will measure postoperative pain scores, total amount of analgesic consumption and motor ability postoperatively.

Who can participate

Age range18 Years – 100 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients over 65 * Patients scheduled for proximal femoral nailing * Patients with American Society of Anesthesiologists (ASA) Physical Status classification of I to IV. Exclusion Criteria: * refusal to participate * a history of neurological deficits or neuropathy * infection at the site of block application * coagulopathy * allergy to local anaesthetics * patients with severe cardiopulmonary insufficiency or renal impairment * mental illness. * prolonged surgery due to orthopaedic complications of more than 3 hours, necessitating conversion of spinal anaesthesia to general anaesthesia.

What they're measuring

pain scores

Timeframe: postoperative 24 hour

Trial details

NCT IDNCT06277648

SponsorHaseki Training and Research Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-06-01

View on ClinicalTrials.gov More Collum Femoris Fracture trials